Biosensors International
Biosensors International (Booth 1456) is featuring clinical data for its BioMatrix Biolimus A9, its new bioresorbable drug-eluting stent platform, which is not yet available in the U.S.

BioMatrix is mounted on a low-profile delivery system enabling access to difficult lesions and vessel physiologies. In combination with its proprietary drug, Biolimus A9, has a bioresorbable polylactic acid polymer coating which is co-released with Biolimus A9, reaching therapeutic concentrations during therapeutic window when cells are proliferating. The Biolimus A9 is eluted from bioabsorbable PLA-coated stent in de novo coronary lesions.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup